BusinessWorld Online runs a piece arguing weight loss drugs such as Ozempic are fueling a health problem that gets little attention.
Recap by typeshit. Full story at BusinessWorld Online.
Mounjaro became India's top-selling drug in 2025, and a Scroll investigation reports that pharmacies are handing it out without the prescription it requires.
The Sunrise health expert says unregulated peptide use can put people in hospital, and in the worst cases leave them needing a new liver.
Some people on weight loss drugs are testing lower doses, hoping for fewer side effects. ThePrint reports on the trend, which these users describe themselves.
Bell raises the question of muscle loss for people losing weight on a GLP-1 and notes it isn't medical advice, pointing viewers to their doctor.
The platform will become a subscription feature in the Health Lives Here app, with revenue shared between the companies. It's a company press release.
A market update credits new generics and steady prices for the rise in sales value, with Eli Lilly's tirzepatide featured in the numbers.
Loading…